Frontiers in Clinical Drug Research – Alzheimer Disorders Volume 6

by Atta -ur-Rahman (Author)

Frontiers in Clinical Drug Research – Alzheimer Disorders is a book series that focuses on Alzheimer’s disease (AD), a neurodegenerative condition that causes dementia or loss of brain function. The disease mainly affects the parts of the brain that deal with memory, thought, and language, and its prevalence has been increasing in recent decades.

In the sixth volume of this series, readers will find critical discussions on AD management and new therapies. The book features chapters covering essential topics such as the treatment of brain inflammation in Alzheimer’s disease with traditional medicine, stem cell strategies for the modelling and therapy of Alzheimer’s disease, retinal neurodegeneration in Alzheimer’s disease, biological mass spectrometry for diagnosis of Alzheimer’s disease and more.

What is particularly exciting and unique about Frontiers in Clinical Drug Research – Alzheimer Disorders is its focus on drug therapy of this specific neurodegenerative condition and related brain disorders, providing relevant reviews written by experts in the field of Alzheimer’s Disease research. The book offers readers an in-depth analysis of the latest advancements and challenges in AD research.

The author of this book series, Atta-ur-Rahman, is a leading scientist and scholar who has been bestowed with numerous awards and titles, including Sitara-i-Imtiaz and the UNESCO Science Prize. He has published over 1,000 research papers and authored or edited over 150 books, making valuable contributions to the field of science and education.

The book has been published by Bentham Science Publishers, a reputable publishing house with years of experience in the industry. The digital version of the book spans over 204 pages, providing readers with comprehensive information on the latest developments in Alzheimer’s disease and its treatments.

Readers will appreciate the attention to detail in the book, with an in-depth analysis of the latest scientific research and trends. From discussion on the various treatments available for Alzheimer’s disease to the role of traditional medicine in managing brain inflammation, readers will find new and exciting information that will change their perspective on this disease’s management.

One highlight of this book is its accessibility to a broad range of readers, regardless of their knowledge or experience level. The book’s language is easy-to-understand, and the content is presented in a clear, concise manner. This makes the book suitable for students, researchers, practitioners, and even the general public, interested in keeping abreast of the latest developments in Alzheimer’s disease research.

Overall, if you’re interested in keeping up with the latest AD drug research and developments in therapies, then Frontiers in Clinical Drug Research – Alzheimer Disorders is a must-read book series. It is packed with vital information that will broaden your knowledge and provide valuable insights into this critical area of healthcare.

Ordering a copy of the book will undoubtedly help you stay informed and up-to-date on Alzheimer’s disease advancements like no other. You will come away with new and exciting knowledge, which you can use to make informed decisions about AD management and treatments. So, don’t hesitate, do your brain and yourself a favour and order a copy of Frontiers in Clinical Drug Research – Alzheimer Disorders today, or its video counterpart.

Product Details

• : 204 pages
• Publisher: Bentham Science Publishers (August 1, 2017)
• Language: English
• ISBN-10: 168108340X
• ISBN-13: 978-1681083407
• Product Dimensions: 7 x 0.5 x 10 inches